Advances in medicine and biology. Volume 39 /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York :
Nova Science,
©2012.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- ADVANCES IN MEDICINE AND BIOLOGYVOLUME 39; ADVANCES IN MEDICINE AND BIOLOGY; ADVANCES IN MEDICINE AND BIOLOGY; VOLUME 39; Library of Congress Cataloging-in-Publication Data; Contents; Preface; CHAPTER 1. Effects of Embryo Transferon the Phenotype; Abstract; Abbreviations; Introduction; 1. Phenotypic Alterations Observedafter Embryo Transfer; 1.1. Birth Weight, Morphogenesis and Malformations; 1.1.1. Ruminants; 1.1.2. Mice; 1.1.3. Humans; 1.2. Brain Development and Behaviour; 1.2.1. Mice; 1.2.2. Humans; 2. Potential Factors Influencing the Phenotype.
- 2.1. Many Factors Act Through Genomic Imprinting2.2. Role of Superovulation; 2.2.1. Superovulation Protocols; 2.2.2. Effect of Superovulation on Imprinting of Oocyte; 2.2.2.1. Ruminants; 2.2.2.2. Mice; 2.2.2.3. Humans; 2.2.3. Chromosomal Abnormalities Following Superovulation; 2.2.3.1. Ruminants; 2.2.3.2. Mice; 2.2.3.3. Humans; 2.2.4. Effect of Superovulation on Uterine Milieu; 2.2.4.1. Mice; 2.2.4.2. Humans; 2.3. IVF, ICSI; 2.4. Embryo Culturing; 2.4.1. Effect of Culture Conditions on Imprinting; 2.4.1.1. Ruminants; 2.4.1.2. Mice; 2.4.2. Metabolic Disturbances; 2.4.2.1. Ruminants.
- 2.4.2.2. Mice2.5. Impact of Transfer Procedure per Sec; 2.5.1. Effect of Transfer Procedure on Imprinting; 2.5.2. Synchrony; 2.5.3. Surgical Procedure; 2.6. Prenatal Maternal Factors; 2.6.1. Strain of Foster Mother; 2.6.2. Hormones and Stress; 2.6.3. Nutrition of Foster Mother; 2.7. Postnatal Maternal Factors; 2.7.1. Diet of Foster Mother; 2.7.2. Differences in Maternal Care; 2.7.3. Interaction between Strain of Embryo and Foster Mother; 2.7.4. Other Environmental Factors; Conclusion; References; CHAPTER 2. Natural Products as a Sourceof Potential Drugs for the Treatmentof Fungal Infections.
- Abstract1. Introduction; 2. Natural Products from Microorganismas Antifungal Agents; 2.1. Natural Products Require More-advanced Studies for the Treatmentof Fungal Infections; 2.2. Novel Natural Products with Antifungal Activities; 3. Biological Activity and Therapeutic Applicationsof Biosurfactants; 3.1. Glycolipids; 3.2. Lipopeptides; 3.3. Anti-adhesive Activities of Biosurfactants; 4. Antifungal Activity of Plants; 4.1. Medicinal Plants with Antifungal Activity; 4.2. Compounds from Plants with Antifungal Activity; 5. Conclusion; Acknowledgment; References.
- CHAPTER 3. Invasive Fungal Infectionsin Immunocompromised Patients:Prevention, Diagnosis and TreatmentAbstract; Introduction; Clinical Manifestation of Particular; Symptoms and Sign of Infections; Laboratory Findings; Treatment; Prevention of Fungal Infections; Conclusion; Acknowledgements; References; CHAPTER 4. Embryo Transfer: State of the Art; Abstract; I. Introduction; II. Timing and Criteria for Embryo Selection; III. Type of the Catheter; IV. Embryo Transfer Medium (ET Medium); V. Ease of Transfer; VI. Ultrasound before Embryo Transfer; VII. Trial Transfer.